Pivotal bioVenture Partners Fund I, L.P. - Aug 1, 2023 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
Director
Signature
Pivotal bioVenture Partners Fund I, L.P. By: Robert Hopfner Managing Partner /s/ Robert Hopfner
Stock symbol
INZY
Transactions as of
Aug 1, 2023
Transactions value $
$3,999,998
Form type
4
Date filed
8/3/2023, 08:13 PM
Previous filing
Apr 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INZY Common Stock Purchase $571K +119K +4.25% $4.80 2.92M Aug 1, 2023 See footnotes F1, F2, F3
transaction INZY Common Stock Purchase $3.43M +714K +83.3% $4.80 1.57M Aug 1, 2023 See footnotes F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held directly by Pivotal bioVenture Partners Fund I, L.P ("Pivotal I").
F2 The general partner of Pivotal I and Pivotal bioVenture Partners Fund II, L.P ("Pivotal II") is Pivotal bioVenture Partners Fund I G.P., L.P. ("Pivotal GP"). The general partner of Pivotal GP is Pivotal bioVenture Partners Fund I U.G.P., Ltd (the "Ultimate General Partner"). The Ultimate General Partner is wholly-owned by Pivotal Partners Ltd ("Pivotal Partners"). Pivotal Partners is wholly-owned by Pivotal Life Sciences Holdings Limited ("Pivotal Life Sciences"). Pivotal Life Sciences is wholly-owned by Nan Fung Life Sciences Holdings Limited ("Nan Fung Life Sciences"), and Nan Fung Life Sciences is wholly owned by NF Investment Holdings LImited ("NFIHL"), which is wholly owned by Nan Fung Group Holdings Limited ("NFGHL").
F3 The members of the Executive Committee of NFGHL make investment decisions with respect to the securities of the Issuer held by Pivotal. Mr. Kam Chung Leung, Mr. Frank Kai Shui Seto, Mr. Vincent Sai Sing Cheung, Mr. Pui Kuen Cheung, Ms. Vanessa Tih Lin Cheung, Mr. Meng Gao and Mr. Chun Wai Nelson Tang are the members of the Executive Committee of NFGHL. Robert Hopfner, a managing partner of the Ultimate General Partner, is a member of the board of directors of the Issuer. Such person's and entities disclaim beneficial ownership over such securities except to the extent of any pecuniary interest therein.
F4 Held by Pivotal II.